LPM3770164 sustained-release tablets

LPM3770164 · Luye Pharma Group Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LPM3770164 sustained-release tablets, covering 2025-01-22 to 2025-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia [Phase 1, Phase 2]

See pricing